We are live on ! Find out more
QNTM icon

Quantum Biopharma Class B Subordinate Voting Shares

28 hedge funds and large institutions have $1.97M invested in Quantum Biopharma Class B Subordinate Voting Shares in 2026 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 8 increasing their positions, 2 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 2

144% more capital inflows, than outflows

Capital inflows: $727K | Capital outflows: $298K

50% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 4

8% more funds holding

Funds holding: 26 → 28 (+2)

3.49% more ownership

Funds ownership: 10.88% → 14.37% (+3.5%)

Holders
28
Holders Change
+2
Holders Change %
+7.69%
% of All Funds
0.34%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
8
Reduced
2
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

QNTM Hedge Fund Activity: Q3 2026 in Review

28 of the 8,221 institutional investors tracked by Wall St. Rank reported a position in Quantum Biopharma Class B Subordinate Voting Shares (QNTM) for Q3 2026, worth a combined $1.97M — up 31% from $1.5M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new QNTM positions and 4 closed out — a net gain of 2 holders — while 8 added to existing stakes and 2 trimmed.

The largest buyer was AdvisorShares Investments, adding an estimated $656K. The largest seller was Jane Street, exiting entirely with an estimated $175K sold.

  • 28 institutional investors held Quantum Biopharma Class B Subordinate Voting Shares (QNTM) as of Q3 2026, up from 26 in Q2 2026.
  • Funds reported $1.97M of Quantum Biopharma Class B Subordinate Voting Shares stock for Q3 2026, up 31% quarter-over-quarter.
  • 6 funds opened new Quantum Biopharma Class B Subordinate Voting Shares positions in Q3 2026 and 4 closed out, a net change of +2 holders.
  • The largest Quantum Biopharma Class B Subordinate Voting Shares buyer in Q3 2026 was AdvisorShares Investments, an estimated $656K added.
  • The largest Quantum Biopharma Class B Subordinate Voting Shares seller in Q3 2026 was Jane Street, an estimated $175K sold.

Based on aggregated 13F filings for Q3 2026.